Share on StockTwits
 

Shares of Johnson & Johnson (NYSE:JNJ) was the target of unusually large options trading activity on Tuesday. Stock traders acquired 13,290 put options on the company, American Banking and Market News reports. This is an increase of approximately 142% compared to the typical daily volume of 5,496 put options.

A number of analysts have recently weighed in on JNJ shares. Analysts at Ned Davis Research upgraded shares of Johnson & Johnson from a “neutral” rating to a “buy” rating in a research note to investors on Monday, January 13th. Separately, analysts at Barclays downgraded shares of Johnson & Johnson from an “overweight” rating to an “equal weight” rating in a research note to investors on Friday, January 10th. They now have a $99.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Johnson & Johnson in a research note to investors on Thursday, January 9th. They now have a $99.00 price target on the stock. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $81.53.

Johnson & Johnson (NYSE:JNJ) opened at 94.03 on Wednesday. Johnson & Johnson has a 1-year low of $72.47 and a 1-year high of $95.99. The stock’s 50-day moving average is $93.05 and its 200-day moving average is $91.31. The company has a market cap of $265.3 billion and a price-to-earnings ratio of 21.20.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, January 21st. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.04. The company had revenue of $18.40 billion for the quarter, compared to the consensus estimate of $17.95 billion. During the same quarter in the prior year, the company posted $1.19 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Analysts expect that Johnson & Johnson will post $5.48 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 11th. Stockholders of record on Tuesday, February 25th will be given a dividend of 0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 2.81%. The ex-dividend date of this dividend is Friday, February 21st.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.